Table 2.

Differences in clinical parameters in patients with or without increased physical activity

Parameters	Units	Baseline period	Follow-up period	P value
Patients without increased PA
Body weight	kg	67.7 ± 3.8	68.3 ± 4.1	0.201
Aspartic aminotransferase	IU/L	41.9 ± 3.9	37.6 ± 3.4	0.238
Alanine transaminase	IU/L	59.2 ± 8.5	47.0 ± 5.8	0.067
Platelets	109/L	210.6 ± 16.8	203.1 ± 16.8	0.629
FIB-4 index		2.10 ± 0.28	2.24 ± 0.36	0.459
FIB-4 index ≥ 2.67	n (%)	7 (35)	5 (25)	0.731
γ-Glutamyltransferase	IU/L	77.4 ± 15.8	58.3 ± 9.0	0.054
Lactate dehydrogenase	IU/L	209.6 ± 11.7	202.4 ± 8.2	0.279
Alkaline phosphatase	IU/L	269.1 ± 20.6	269.8 ± 24.7	0.944
Total bilirubin	mg/dL	0.66 ± 0.06	0.73 ± 0.06	0.360
Total cholesterol	mg/dL	190.0 ± 7.6	191.8 ± 8.3	0.716
Triglycerides	mg/dL	146.7 ± 18.1	179.3 ± 25.6	0.136
Albumin/globulin ratio		1.48 ± 0.04	1.46 ± 0.04	0.526
Patients with increased PA
Body weight	kg	69.5 ± 3.3	67.8 ± 3.3	0.104
Aspartic aminotransferase	IU/L	61.4 ± 7.8	37.5 ± 3.0	0.004
Alanine transaminase	IU/L	95.3 ± 10.8*	49.5 ± 5.9	< 0.001
Platelets	109/L	227.8 ± 12.8	231.6 ± 12.8	0.584
FIB-4 index		1.77 ± 0.24	1.56 ± 0.20	0.187
FIB-4 index ≥ 2.67	n (%)	5 (20)	4 (16)	1.000
γ-Glutamyltransferase	IU/L	89.1 ± 19.3	60.0 ± 11.5	0.015
Lactate dehydrogenase	IU/L	201.0 ± 7.5	194.4 ± 7.6	0.188
Alkaline phosphatase	IU/L	301.1 ± 33.6	284.9 ± 35.3	0.651
Total bilirubin	mg/dL	1.17 ± 0.32	0.93 ± 0.11	0.373
Total cholesterol	mg/dL	207.3 ± 9.1	205.9 ± 8.9	0.594
Triglycerides	mg/dL	186.7 ± 25.9	166.4 ± 31.8	0.292
Albumin/globulin ratio		1.35 ± 0.05	1.39 ± 0.06	0.268

Data are presented as n (%) or mean ± standard error

FIB-4 fibrosis-4, PA physical activity

*P < 0.05, comparison between patients without increased PA and patients with increased PA during the baseline period